arginine has been researched along with perindopril in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bennett, MA; Hillier, C; Thurston, H | 1 |
| Cooper, ME; Komers, R; Rumble, JR | 1 |
| Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Giunta, R; Marfella, R | 1 |
| Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A | 2 |
| Hirata, Y | 1 |
| Remko, M | 1 |
| Galiavich, AS; Galiavich, RA; Khamidullina, AR | 1 |
| Ge, J; Guo, Y; Huo, Y; Jin, Y; Li, G; Li, H; Luo, J; Ma, C; Miao, P; Qi, L; Shen, F; Shi, H; Wang, B; Wang, F; Wu, S; Wu, X; Xu, D; Xu, G; Yang, J; Zhao, S | 1 |
| Ostroumova, OD | 1 |
| Kobalava, ZD; Tolkacheva, VV; Troitskaya, EA | 1 |
| Borisova, EV; Kochetkov, AI; Ostroumova, OD | 1 |
| Begrambekova, YL; Levin, AM; Mareev, VY; Minina, YV | 1 |
| Czaklosz, P; Gorniak, K; Ibragimow, I; Kus, M; Olejnik, A; Piotrowska-Kempisty, H; Skupin-Mrugalska, P | 1 |
| Ackbarkhan, A; Mbanya, A; Mbanya, JC; Mittoo, MY; Ramamonjisoa, HA; Ramilitiana, B; Ranivoharisoa, EM; Ratsimbazafy, SJN | 1 |
| Almalki, MA; Binsaleh, AY; Mahmoud, OA; Mohamed, MA; Omran, AA | 1 |
2 review(s) available for arginine and perindopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[NO and hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Arteriosclerosis; Biopterins; C-Reactive Protein; Endothelium, Vascular; Humans; Hypertension; Mutation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species; Vasodilation | 2004 |
3 trial(s) available for arginine and perindopril
| Article | Year |
|---|---|
Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Blood Viscosity; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Indoles; Leg; Male; Middle Aged; Perindopril; Platelet Aggregation; Propanolamines; Reference Values; Regional Blood Flow; Rheology; Vascular Resistance | 1998 |
Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Bisoprolol; Blood Pressure; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; von Willebrand Factor | 2001 |
[Efficacy comparison between 5 mg perindopril arginine salt and 4 mg perindopril tert-butylamine salt for patients with mild to moderate essential hypertension].
Topics: Antihypertensive Agents; Arginine; Blood Pressure; Butylamines; Double-Blind Method; Essential Hypertension; Humans; Hypertension; Perindopril; Sodium Chloride | 2015 |
13 other study(ies) available for arginine and perindopril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine.
Topics: Acetylcholine; Amlodipine; Animals; Antihypertensive Agents; Arginine; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydralazine; Hypertension; Indoles; Isoquinolines; Mesenteric Arteries; Nitroarginine; Perindopril; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines; Vasodilation | 1996 |
Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Diabetic Angiopathies; Hypertrophy; Indoles; Kinins; Male; Mesenteric Arteries; Nitric Oxide; Nitroarginine; Perindopril; Rats; Rats, Wistar | 1996 |
Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunoassay; Male; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Perindopril; Renin-Angiotensin System; von Willebrand Factor | 2002 |
Molecular structure and stability of perindopril erbumine and perindopril L-arginine complexes.
Topics: Antihypertensive Agents; Arginine; Drug Stability; Ions; Models, Molecular; Molecular Structure; Perindopril; Solubility; Solvents; Structure-Activity Relationship; Thermodynamics | 2009 |
[Effect of antihypertensive drugs on some humoral parameters of endothelial function].
Topics: Aged; Antihypertensive Agents; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Follow-Up Studies; Humans; Hypertension; Indapamide; Middle Aged; Nitrous Oxide; Perindopril; Treatment Outcome; Vasodilation | 2009 |
[Efficacy and Safety of a Fixed Combination of Perindopril Arginine and Amlodipine in Patients With Hypertension Uncontrolled by Treatment With Angiotensin II Receptor Blockers in Real Clinical Practice. Results of the PREVOSHODSTVO (SUPERIORITY) Program]
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arginine; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2017 |
[Combined Therapy of Arterial Hypertension With Triple Fixed-Dose Combination of Amlodipine/Indapamide/Perindopril Arginine in Real Clinical Practice: the Organization and the Main Results of the DOKAZATEL'STVO (Proof) Study].
Topics: Academic Medical Centers; Aged; Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Patient Compliance; Perindopril; Russia | 2018 |
[Single Pill Indapamide and Perindopril Arginine Combination: Optimal Coupling of Vascular Protection and Hemodynamic Risk Factors Reduction in Patients with Essential Arterial Hypertension].
Topics: Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Retrospective Studies; Risk Factors | 2019 |
[Therapeutic approaches to the Rational Use of trip-le combination therapy with a fixed combination of amlodipine, indapamide and perindopril arginine (TRIPLE COMBINATION) in patients with hypertension who do not control blood pressure on conventional tre
Topics: Aged; Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Quality of Life; Treatment Outcome | 2020 |
Permeability of the Perindopril Arginine under In Vitro Conditions across Caco-2 Monolayer and Biomimetic Phospholipid Membrane.
Topics: Arginine; Biological Transport; Biomimetics; Caco-2 Cells; Cell Membrane Permeability; Humans; Intestinal Absorption; Perindopril; Permeability; Phospholipids | 2022 |
Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius.
Topics: Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Madagascar; Mauritius; Perindopril; Treatment Outcome | 2022 |
Chromatographic Techniques for Assessment of Bisoprolol Fumarate and Perindopril Arginine in Solid Formulations under Various Stress Conditions and Application to Six Sigma, Content Uniformity, and Comparative Dissolution Approaches.
Topics: Arginine; Bisoprolol; Perindopril; Solubility; Total Quality Management | 2023 |